Caroline E. Munoz

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Pathobiology of atopic dermatitis and association with disease severity after acute oral steroid treatment.

Pathobiology of atopic dermatitis and association with disease severity after acute oral steroid treatment.

Journal: The journal of allergy and clinical immunology. Global

Published: October 07, 2025

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.

Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration.

Journal: BMJ open

Published: May 30, 2025

Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.

Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study.

Journal: International journal of cancer

Published: August 12, 2024

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer.

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: February 09, 2024

Cost-Effectiveness Analysis of Bevacizumab Biosimilars Versus Originator Bevacizumab for Metastatic Colorectal Cancer: A Comparative Study Using Real-World Data.

Cost-Effectiveness Analysis of Bevacizumab Biosimilars Versus Originator Bevacizumab for Metastatic Colorectal Cancer: A Comparative Study Using Real-World Data.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: January 20, 2024

Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Journal: Current oncology (Toronto, Ont.)

Published: January 10, 2024

Comparative Safety and Effectiveness of Bevacizumab Biosimilars to Originator for the Treatment of Metastatic Colorectal Cancer.

Comparative Safety and Effectiveness of Bevacizumab Biosimilars to Originator for the Treatment of Metastatic Colorectal Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 22, 2023

Factors associated with intention for revaccination among patients with adverse events following immunization.

Factors associated with intention for revaccination among patients with adverse events following immunization.

Journal: Vaccine

Published: May 19, 2023

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.

Journal: Current oncology (Toronto, Ont.)

Published: February 21, 2023

Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.

Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: February 09, 2023

Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned.

Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned.

Journal: Current oncology (Toronto, Ont.)

Published: June 09, 2022

Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization.

Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization.

Journal: The Journal of pediatrics

Published: March 26, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026